Idexx Laboratories | IDXX - Current Liabilities



Idexx Laboratories reported $1.22B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Abbott USD 13.44B 435M Jun/2025
Align Technology USD 2B 4.54M Jun/2025
Dentsply International USD 1.17B 627M Jun/2025
Dexcom USD 3.31B 271.6M Jun/2025
Edwards Lifesciences USD 1.39B 110.4M Mar/2025
Fujifilm JPY 1.06T 64.7B Jun/2025
Globus Medical USD 424.66M 39.96M Jun/2025
Henry Schein USD 3.01B 90M Jun/2025
Hologic USD 962.5M 27.2M Jun/2025
Idexx Laboratories USD 1.22B 87.67M Jun/2025
Insulet USD 1.01B 489.7M Jun/2025
Integra LifeSciences USD 929.81M 11.35M Jun/2025
Intuitive Surgical USD 2.21B 197.4M Jun/2025
Masimo USD 592.1M 45.6M Jun/2025
Neogen USD 174.01M 32.81M May/2025
ResMed USD 1.02B 78.6M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Steris USD 926.6M 95.57M Jun/2025
Tandem Diabetes Care USD 251.69M 36.48M Jun/2025
Teleflex USD 716.15M 40.24M Jun/2025
Thermo Fisher Scientific USD 12.72B 456M Jun/2025
Zoetis USD 3.37B 19M Jun/2025